3.1 Search Results
The process of selecting the studies is described in Fig. 1. We retrieved 9,303 records in our search. After reviewing the abstracts and full texts, we included 112 studies. Among them, 53 were from Chinese databases and 59 were from English databases. The most common method of modelling was ovariectomy for females and testicle removal was performed in males9–21. The second method was the animal model of castration combined with drugs1 22–35. A few other modelling methods, such as drug modelling alone28 36–43, nutritional deficiency modelling44–48, disuse modelling16 49 50 and gene knockout modelling51–56 were used in the retrieved studies. (Table 1. Table of general characteristics of the included English studies)
3.2 Selection of experimental animals for research model
It is very important to select the correct osteoporosis model animal. Different osteoporosis models, including animal species and human bone tissues, have different histological and biological metabolism characteristics. Measurements of basic bone mass vary for different ages and genders, and choosing the animal species for an osteoporosis model is very strict. At present, the commonly used animals include rats, mice, dogs, sheep, rabbits, pigs and primates57–61. Rodents (including rats and mice) have been used in over 60% of the studies, followed by sheep and rabbits, according to the results of our survey. Other non-human primates, such as pigs and dogs, have also been used, but in relatively small numbers.
The rat is the most frequently used laboratory animal for studying osteoporosis and it has become the most used and mature model animal for osteoporosis. Rodents are often chosen for models because they are inexpensive and easy to maintain, grow quickly, have a relatively short lifespan, have good skeletal characteristics, and are widely available. Rodents have many similarities with humans, including their genomes62. Bone loss occurs with age, a similar distribution of cancellous bone, a high bone conversion rate after ovariectomy, decrease in intestinal calcium absorption, and a similar response to sex hormones45 63.
Because of the clear understanding of the mouse genome, mice have become a common experimental animal in the field of bone mass gene control. Mice are often used to study the genetic factors of bone metabolism, importing or knocking out target genes, and observing phenotype and pathological changes. Mice are primary experimental model animals in the study of influential genetic factors on peak bone mass and age-related bone loss 62. However, the disadvantages are: the epiphysis closure is slow and the bone reconstruction cycle is shorter than that of humans, which may interfere with the experimental results. Because ovariectomy does not cause brittle fractures, it is not suitable for the study of cortical bone changes after ovariectomy. The life cycle of rats is short and the blood volume is small so it is often impossible to take blood and biopsy samples. The biological cycle of rodents is significantly different from that of humans and this may produce errors in experiments. These issues draw attention to the need for models that more closely mimic humans64. The lack of a Haversian reconstruction system and low activity of cortical reconstruction is not suitable for evaluating drugs promoting the role of Haversian reconstruction 63 65.
Compared with rodents, adult rabbits have obvious Haversian system reconstruction ability, a faster bone turnover rate16 and earlier epiphyseal closure (usually 6–8 months) 766. According to the results of the included literature, rabbits have been used more often for ovariectomised, glucocorticoid and ovariectomised + glucocorticoid osteoporosis animal modelling 1617272832. Other animals, such as sheep, pigs, dogs62 and non-human primates also have a Haversian reconstruction system, and non-human primates are genetically closer to humans and have similar oestrus cycles64. However, they are expensive2267, difficult to manage 3157, and hormonal changes have little impact on bone loss 1061, so they are not used in models of osteoporosis.
Ideal experimental animal models would include absolute replication of human diseases. Unfortunately, this goal has not been achieved in the study of osteoporosis. Rats, mice, dogs, monkeys and apes are the main animals that have been used to simulate osteoporosis. Each species has its own advantages and disadvantages and not one of the experimental animal species includes all risk factors associated with an osteoporosis model62.
3.3 the basis for judging the effect of the modeling method
Since the lumbar spine, femur and tibia are the most common clinical fracture sites, most experiments have measured the BMD and bone mineral content (BMC) in these bones. The main measurement method is scanning with a dual-energy X-ray (DXA) instrument. Next, bone histometrics, biochemical parameters of blood samples (e.g. calcium and phosphorus), and bone biomechanics indexes have been determined. For postmenopausal osteoporosis, because the incidence of this type of osteoporosis is related to a decrease in oestrogen, the estradiol can be increased when comparing various indicators. All the above indicators can reflect the osteoporosis situation in animals from different aspects. It is necessary to comprehensively analyse a variety of indicators to achieve a comprehensive judgement on modelling effects.
3.4 Common animal models
3.4.1 Primary osteoporosis model
(1) Postmenopausal osteoporosis model (PMOP)
The OVX rat model is a classic model of PMOP68,and it has been widely adopted to mimic oestrogen-deficiency-induced bone loss18. OVX can induce a decrease in oestrogen levels and increase the recruitment, differentiation and survival of osteoclasts so that bone resorption exceeds bone formation, which eventually leads to osteoporosis7.
In this model, bilateral ovaries are resected in a sterile environment, which results in a rapid decrease of oestrogen, enhanced bone turnover and increased bone resorption, resulting in osteoporosis69. The bone mass loss after modelling was mainly trabecular bone loss, which is similar to the bond loss in postmenopausal women. The Food and Drug Administration (FDA) has suggested that rats aged 6–10 months should be used to establish the model, which is usually 12 weeks or longer after castration70. Surgical castration has been widely used because of its single modelling factor, definite modelling effect, good repeatability, high reliability of experimental results, and it can accurately reflect the cause of oestrogen decline, which successfully simulates the characteristics of postmenopausal osteoporosis bone metabolism.
However, there are still some controversies. First, oestrogen levels in animals suddenly and rapidly decrease after oophorectomy, while oestrogen decreases are long and slow processes in the natural course of disease, and ovarian stromal cells in postmenopausal women still have some endocrine function. Second, surgical castration itself is traumatic, which may cause a negative nitrogen balance, stress response and electrolyte disorder, which may affect the detection of indicators. Third, ovarian resection may lead to weight gain in rats, and weight gain may partially protect against bone loss. Finally, when oestrogen replacement therapy was studied in a castrated rat model, the fertility status of the rats affected the experimental results.
In addition, the removal of male testis can also be used to construct an osteoporosis model. These models have been used in the study of basic theory and drug intervention in male osteoporosis and significant results have been achieved. However, due to the continuous growth of the adult male epiphysis after 30 months, the experimental results using male rats are not widely accepted by scholars.
The effect of OVX on bone is not consistent in different bone sites71. Loss in long bones, including the tibia, femur, humerus and ulna, was reported at 36 weeks after ovariectomy (75.0%, 70.4%, 64.9% and 57.1%, respectively), compared with that of the lumbar spine and iliac bone (36.6% and 51.6%, respectively) 18. In addition, only the ulna, femur and tibia showed significant bone loss at four weeks after OVX, indicating that these areas were more sensitive to OVX18. Also, OVX-induced bone loss is more severe and observed earlier in the proximal tibia than in the lumbar spine or femur, so short-term studies of the proximal tibia are recommended71. The use of rabbits16 17, rodents (rats and mice) 11–13 18 21, sheep15 and non-human primates as animal models of OVX osteoporosis is recommended. We prefer rabbits and rats for reasons of economics, experiment time and animal ethics.
(2) Senile osteoporosis model (SAM)
Primary osteoporosis includes postmenopausal osteoporosis and senile osteoporosis. In both males and females, the loss of cancellous bone (also known as trabeculae) begins at thirty years old and there is rapid loss during menopause. On the other hand, most cortical bone loss occurs at 10 years after menopause due to cortical thinning and increased cortical porosity60 71. Bones in most mammals are thought to deteriorate with age, but in animals commonly used in biological research, age-related bone loss is only well documented in crab-eating monkeys64, sheep (6 ~ 10 years old) 72, rats and mice73–77.
Rats typically live two to three years, with bone mass peaking at 4–8 months of age and then declining with age78. Watanabe et al. 78 introduced several classic models of age-related osteoporosis in which the strains of mice were C57BL/6, BALB/C and senescence accelerated mice (SAM) 74–76. However, inbred mice (C57BL/6 and BALB/C) were prone to die of cancer79, which affected the process of subsequent experiments. Takeda80 and his colleagues established a SAM composed of SAMP and SAMR series. Compared with normal mice, SAMR and SAMP had accelerated ageing. Senescence-accelerated mouse prone 6 (SAMP6) was reported as the first mouse model of spontaneous senile osteoporosis76. Only one of the articles included in our study used SAMP6 rats as model animals51. Azuma et al. 74 found that SAMP6 mice have many morphologic and molecular features that mimic human bone ageing, and they are considered as a useful experimental model for the spontaneity of age-related osteoporosis76.
(3) Gene recombination animal model of osteoporosis
Developments in genetic technology have made it possible to create animal models with specific genetic traits by silencing or knocking out a particular gene. Gene technology used in osteoporosis modelling mainly includes gene knockout technology and gene mutation technology. Most of the mice treated with gene technology were used to study primary osteoporosis. For example, osteoprotegerin knockout mice (OPG−/−)81 were used to study postmenopausal osteoporosis, and gene mutation mice SAMP6 were used to study ageing osteoporosis75. Some studies reported that various genes, cytokines and pathways were associated with BMD, osteoporosis, or fractures82–84. Compared with the classical castrated rat model, SAMP6 has obvious advantages. It has a clear genetic background and avoids interference from the external environment as much as possible. Osteoporosis can occur in the early postnatal period, which can shorten the experiment time. Without surgical intervention, the negative nitrogen balance of the model animals did not occur, and there was little influence on the internal environment related to sex hormones in vivo. However, its high price, complicated process and technical difficulty undoubtedly limit its application.
3.4.2 Secondary osteoporosis model
(1) Glucocorticoid Osteoporosis (GIOP)
Due to the wide application of glucocorticoids in the clinic, the incidence of osteoporosis caused by glucocorticoids is second only to postmenopausal osteoporosis and senile osteoporosis, and ranks first in secondary osteoporosis. Induction methods include gavage, oral administration and intramuscular injection. The treatment drugs usually mediate prednisone; e.g. methylprednisone and occasionally high-potency dexamethasone. Significant bone loss occurs as early as 10 days and as late as 48 weeks after use. However, this model is not fully suitable for evaluating the inhibitory effects of drugs on bone resorption, because glucocorticoid-induced osteoporosis is not consistent with the pathogenesis and course of primary osteoporosis. Rats, mice, rabbits85, sheep26, pigs41 and dogs can be used as models in this method. The rabbits are sensitive to glucocorticoid induction, and the modelling time is short32. Rats are usually the dominant model and can be successfully modelled after 5–6 weeks.
(2) Retinoic Acid (RA)
Retinoic acid, a derivative of vitamin A, can activate osteoclasts and promote bone resorption, but it does not inhibit the activity of osteoblasts and has no obvious effect on bone formation and the mineralisation process of the bone matrix. As a result, bone remodelling is in a negative balance state with bone resorption greater than bone formation, and this ultimately leads to osteoporosis in animals. Although the pathogenic factors of this model are different from the clinical factors, it is similar to humans regarding symptoms, histomorphological manifestations and bone responses to oestrogen. In addition, it is a commonly used modelling method for acute osteoporosis in rats due to its short modelling time86 87. Generally, oral administration of retinoic acid or a gavage of 70–105 mg/kg for two consecutive weeks can successfully establish an osteoporosis model, which has good short-term effects but poor long-term effects. This model has the advantages of convenient operation, a high success rate and typical symptoms86, so it is widely used in the research and development of new drugs.
(3) Alcoholic osteoporosis model
The abuse of alcohol is one of the most important lifestyle risk factors for osteoporosis. Microanatomical changes in the skeletons of alcohol-dependent rats were later identified in human alcoholics, providing evidence that rats are useful for forecasting human outcomes. The use of this model has brought a better understanding of the pathogeny and severity of alcohol-induced bone loss. Excessive intake of ethanol can cause bone loss62, increased adipose tissue in the bone marrow, altered numbers and activities of osteoblasts and osteoclasts, and increased apoptosis of bone cells, which can lead to secondary osteoporosis88 89. At present, the ethyl alcohol model is only used to study the mechanisms of alcohol-induced osteoporosis.
(4) Disuse osteoporosis model
Disused osteoporosis models, which include surgical and non-surgical methods, are of great significance in the study of osteoporosis in paralysis, long-term postoperative bedridden cases, and aviation personnel90 91. Surgical methods include denervation92, tendon removal and spinal cord resection. Non-operative methods include suspension93, bandage binding and screw fixation. Rats have been extensively used as a model for disuse osteoporosis91–93. Each of these seemingly disparate methods lead to similar skeletal changes, implying that the principal impacts on bone loss are due to pressure unloading. These models have been used to study the pathogeny of disuse osteoporosis rats in growth stages and maturity, as well as to evaluate the efficacy of potential interventions62. The results of Peng et al.56 showed that, compared with a control group, the maximum load on the femoral neck was significantly reduced (27.7%, P < 0.001) and the energy absorption was significantly decreased (45.3%, P < 0.001) with immobilisation (IMM).
(5) Brain-derived osteoporosis model
The hypothalamo-pituitary gland system regulates the balance of several hormones, such as thyroid hormones (T3, T4), gonadotropins (LH, FSH), cortisol and leptin and insulin-like growth factor 1 (IGF-1). Hypothalamic-pituitary dissection (HPD) results in significant bone loss in sheep, affecting the trabeculae and cortical bone94. Oheim et al. 30 showed significant trabeculae and cortical bone loss at 24 months after HPD in sheep. Histomorphometric analysis of the iliac crest showed a significant 60% reduction in BV/TV compared to the control group.
Melatonin secreted by the pineal gland can affect bone metabolism. A study by Egermann et al.25 found that bone absorption increased after pineal resection (PX), and cancellous bone volume (BV/TV) decreased by − 13.3% six months later and decreased by − 21.5% if combined with OVX. Thirty months after surgery, there was still continuous bone loss. Although the degree of bone loss caused by this method is not up to the standard of OP (− 2.5SD), it is can be used together with other methods in the construction of osteoporosis models. In addition, lateral ventricular injection of leptin significantly reduced left ventricular bone formation and resulted in significant trabecular loss in sheep31.
3.4.3 Combined osteoporosis Model
Due to the diversity in osteoporosis, a combined modelling method has great practical significance and application value. The combined modelling method not only simulates a variety of mechanisms of osteoporosis, but also has the advantages of a short modelling period and good modelling effect. It has therefore been favoured by many scholars. An osteoporosis model can shorten the modelling time by using other modelling methods combined with castration, such as castration + diet95 and castration + glucocorticoids23 26–29 34 35 85. Generally, the effect of combined modelling on bone mass, bone structure and biomechanical properties is more obvious than that of a single modelling method23.